HEART & LUNG, cilt.49, sa.5, ss.564-571, 2020 (SCI-Expanded, Scopus)
Background: Pulmonary and extrapulmonary impairments are prevalent in pulmonary arterial hypertension (PAH) which is a rare, chronic and progressive disease.